Neurofilament Light Chain Levels in Serum and Cerebrospinal Fluid Do Not Correlate with Survival Times in Patients with Prion Disease
Biomolecules · 2024
DOI: 10.3390/biom15010008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Mika Shimamura und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Support Center, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan. Hauptthemen laut MEDLINE: Neurofilament Proteins, Creutzfeldt-Jakob Syndrome, Prion Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, MHLW Researches on Rare and Intractable Diseases Health, Labour and Welfare Policy Research, MHLW’s Researches on Rare and Intractable Diseases Health, Labour and Welfare Policy Research.
Abstract (Originalsprache)
Prion diseases, including Creutzfeldt–Jakob disease (CJD), are deadly neurodegenerative disorders characterized by the buildup of abnormal prion proteins in the brain. This accumulation disrupts neuronal functions, leading to the rapid onset of psychiatric symptoms, ataxia, and cognitive decline. The urgency of timely diagnosis for effective treatment necessitates the identification of strongly correlated biomarkers in bodily fluids, which makes our research crucial. In this study, we employed a fully automated multiplex ELISA (Ella®) to measure the concentrations of 14-3-3 protein, total tau protein, and neurofilament light chain (NF-L) in cerebrospinal fluid (CSF) and serum samples from patients with prion disease and analyzed their link to disease prognosis. However, in North American and European cases, we did not confirm a correlation between NF-L levels and survival time. This discrepancy is believed to stem from differences in treatment policies and measurement methods between Japan and the United States. Nonetheless, our findings suggest that NF-L concentrations could be an early diagnostic marker for CJD patients with further enhancements. The potential impact of our findings on the early diagnosis of CJD patients is significant. Future research should focus on increasing the number of sCJD cases studied in Japan and gathering additional evidence using next-generation measurement techniques.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Research Support Center, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
- Unit of Medical and Dental Sciences, Department of Health Sciences, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
- Division of Cellular and Molecular Biology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
- Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi 329-0498, Japan.
- Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
- Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, 1-5-45 Yushima Bunkyo-ku, Tokyo 113-8510, Japan.
ORCID-Profile: Mika Shimamura, Toshiaki Nonaka, Koki Kosami, Ryusuke Ae, Taiki Matsubayashi, Katsuya Satoh
Förderung
- Japan Agency for Medical Research and Development
- MHLW Researches on Rare and Intractable Diseases Health, Labour and Welfare Policy Research
- MHLW’s Researches on Rare and Intractable Diseases Health, Labour and Welfare Policy Research
- Research Committee of Prion Disease and Slow Virus Infection
- Research on Policy Planning and Evaluation for Rare and Intractable Diseases
- Health and Labour Sciences Research Grants
- Research Committee of Surveillance and Infection Control of Prion Disease
Zitieren
APA
Shimamura, M., Weijie, K., Nonaka, T., Kosami, K., Ae, R., Fujita, K., Matsubayashi, T., Tsukamoto, T., Sanjo, N., & Satoh, K. (2024). Neurofilament Light Chain Levels in Serum and Cerebrospinal Fluid Do Not Correlate with Survival Times in Patients with Prion Disease. Biomolecules. https://doi.org/10.3390/biom15010008
Vancouver
Shimamura M, Weijie K, Nonaka T, Kosami K, Ae R, Fujita K, et al. Neurofilament Light Chain Levels in Serum and Cerebrospinal Fluid Do Not Correlate with Survival Times in Patients with Prion Disease. Biomolecules. 2024. doi:10.3390/biom15010008
BibTeX
@article{Shimamura2024,
author = {Shimamura, Mika and Weijie, Kong and Nonaka, Toshiaki and Kosami, Koki and Ae, Ryusuke and Fujita, Koji and Matsubayashi, Taiki and Tsukamoto, Tadashi and Sanjo, Nobuo and Satoh, Katsuya},
title = {Neurofilament Light Chain Levels in Serum and Cerebrospinal Fluid Do Not Correlate with Survival Times in Patients with Prion Disease},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom15010008}
}
EUVIMED